Khiron Europe is confident that its efforts in collecting evidence will allow the UK to follow in the footsteps of Germany’s thriving medical cannabis market.
Researchers at the University of Edinburgh have received £1.55 million in grant funding for two Phase II clinical trials.
Despite launching in April 2021 the NHS cannabis patient registry is yet to collect any data.
Patients and advocates in the UK have welcomed the news but warned of a need to ‘manage expectations’.
The project hopes to show that cannabis would be cost-effective if prescribed through the NHS for chronic pain.
New data has revealed the number of private and NHS cannabis prescriptions issued since the law change in November 2018.
Business owners have raised £18,000 to fund Cole Thomson's cannabis medicine throughout 2023.
More than six in 10 NHS trusts did not prescribe any cannabis-based medicines in 2021.
Louis Petit has been seizure-free for two years on medical cannabis.
A full health economic analysis hopes to show cannabis could be prescribed on the NHS at 'net-zero' cost.